Fennec Pharmaceuticals FENC
NASDAQ FENC
$10.64 +0.06 (+0.57%)
At close: Nov 11, 2026 · 4:00 PM EST

Fennec Pharmaceuticals (FENC) Price to Earnings (2024)

Updated

Fennec Pharmaceuticals' (FENC) Price to Earnings stood at 61.05 in Q2 2024, down 42.4% from the prior quarter.

Analysis

Fennec Pharmaceuticals (FENC) Price to Earnings (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Fennec Pharmaceuticals 370.66 Mn 230.50 Mn 17.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 61.05
Mar 31, 2024 105.98
API Access

Fennec Pharmaceuticals Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=FENC&period=max&api_key=YOUR_API_KEY